Abstract
Differentiation of Tfh cell
Tfh cells a r e generated from CD4 + T-cell and transcription repressor B-cell lymphoma 6 (Bcl-6) is one of the important transfer factor 1,2 and IL-21 is the key cytokine which causes differentiation and development of Tfh cell. 3 Danelle 4 created the mice models deficient of IL-6 and IL-21 respectively, and found that only deficiency of IL-6 or IL-21 could not affect the development of Tfh cells, at the time of exiting both could be functional. IL-27 also affected Tfh cell because of enhancing the expression of IL-21. 5 Fazilleau 6 took B10 and BR mice as the models of CI-EK limiting the response of Tfh cell, and proved that the combination ability of TCR with pMHCII and TCR signal intensity could effect Tfh cell differentiation. Moreover, the amount of Tfh cell would increase under the stimulation of adjuvant. Musculoaponeurotic fibrosarcoma (Maf) could induce CXCR5 expression, co-expression of Bcl-6 and Maf revealed that Bcl-6 and Maf cooperate in the induction of CXCR4, PD-1, and ICOS. These findings reveal that Bcl-6 and Maf collaborate to orchestrate a suite of genes that define core characteristics of human Tfh cell biology. 7 
Introduction

Relationship between Tfh cell and other T-cell subgroups
As researches showed 16 , in the Tfh cells of mice, Bcl-6 could inhibit activity of GATA-3 and T-bet, both were inhibited when Bcl-6 was overexpressed, and the amount of Th1, Th2, Th17 decreased accordingly; while these subpopulation increased when Bcl-6 was insufficient. So Bcl-6 downregulated the differentiation and function of T cell subpopulation except for Tfh cells. Nakayamada 17 showed Tfh and Th1 cells share a transitional stage through the signal mediated by STAT4, which promotes both phenotypes, on the other hand, STAT4 could induce the transcription factor T-bet, while Tbet could repress Bcl-6 and other markers of Tfh cells, and constrained Tfh cell expansion and consequent GCs formation and antibody production, while T-bet could repress the functionalities of Tfh cell, and promote Th1 cell differentiation.
Another study reported that, during viral infection, most of the CD4 + T cells did not differentiate into Th1 cell but Tfh cell, this change will be beneficial for virus infection. 18 Interestingly, Tfh cell affected other T cell subgroup not only by inhibiting their secretion of cytokines, but also by enhancing some cytokines which were secreted by other T subpopulations generally, to replace their secretory function. 19 
Tfh and associated diseases
There are two groups of factors that maintain Tfh cell functionality [31] [32] [33] , one is promoter, such as IL-21, IL-6, IL-10, IL-27, Bcl-6, OX40, CXCR3, ICOS; the other is inhibitor, e.g. Blimp-1, PD-1, Treg, DC and PC. Any disorders in these factors causes autoimmune disease, immunodeficient disease, tumor and infectious disease. 
Autoimmune diseases
Rheumatoid arthritis
Some scholars created mice models with collagen induce arthritis (CIA), and then they used monoantibody specific to ICOS to block ICOS signal pathway. As a result, the inflammatory symptom remitted and the production of abnormal GC in synovial membrane decreased. These showed that Tfh cell is the important element for the generation of RA. 37 4. 4.1.5 Type 1 diabetes Type 1 diabetes is an autoimmune disease caused by islet-reactive T cells which destroy insulin-producing β-cells. Diego 40 measured islet-specific CD4 + T cell regulation in T-cell receptor transgenic mice with elevated frequencies of CD4 + T cells recognizing hen egg lysozyme (HEL) autoantigen expressed in islet β-cells, and found that mouse anti-islet IgG antibodies formed as a consequence of excessive Tfh cell activity, progression to diabetes was ameliorated in the absence of B cells or when the B cells could not secrete islet-specific IgG, these indicated that Tfh cell play an important role in T1DM.
Other diseases
Conlon 41 created T cell-deficient mice models with monoclonal populations of TCR-transgenic CD4 + T cells, then transplanted heart from the same species, detected the differentiation of CD4 + T c e lls transferred to the recipients by follicular localization and by acquisition of signature phenotype. They found that the transferred CD4 + T cells differentiated into Tfh cells, and thought that Tfh cells take part in the rejection of organ transplantation.
Immunodefficiencies
According to in vivo or in vitro experiment of Xlinked lymphoproliferative disease (XLP), ICOS produced by CD4 + T cells decreased, there were something wrong with generation of the associated molecules which help for B cells, such as IL-4, IL-10, and the immunity of the patients declined. The same phenomenon existed in Hyper-IgM Syndrome (HIGM). 42, 43 
Infectious diseases
In the study of hepatitis B, researchers found that the frequency of Tfh cells in patients with immuneactive (IA) CHB was significantly higher than that of immune-tolerant (IT) CHB and healthy controls (HC), and the percentages of Tfh cell in IA patients were positively correlated with AST. Furthermore, the percentages of Tfh cells in CHB patients were significantly higher than that of HC. Treatment with adefovir dipivoxil reduced the frequency of Tfh cells, the concentrations of HBsAg and HBeAg, but increased the concentrations of HBsAb, HBeAb, IL-2 and IFN-γ in IA patients. Moreover, the frequency of splenic and liver Tfh cells in HBV-transgenic mice was higher than that of wild-type controls. 44 In peripheral blood of HCV-infected patients, percentage of Tfh cells was higher than healthy controls, and statistically significant n e gative correlation was found between the percentage of Tfh cells and the HCV RNA load. These data suggested that Tfh cells may participate in HCV-related immune responses. 45 In another study, the presence of intrahepatic Tfh cells in livers of HCV-infected patients was detected. The absolute number of liver Tfh cells progressively increased from nonresponders (NRs) to relapsers (RRs) to a maximum in sustained virological response (SVRs) patients, their amount is proportional t o t h e ultimate likelihood of SVR, with a progressive increase from NR to RR to SVR. Quantification of Tfh cells in the liver biopsy of these patients adds useful prognostic information. 46 In the lymph node of rhesus macaques infected with SIVmac239, the progression of SIV infection was accompanied by increased numbers of well-88 delineated follicles containing GCs and Tfh cells, the density of PD-1 expression in lymph nodes progressively increased, and the rise in PD-1 + Tfh cells was followed by a substantial accumulation of Ki67 + B cells within GCs. Moreover, unlike in blood, major increases in the frequency of CD27 + memory B cells were observed in lymph nodes, indicating increased turnover of these cells which correlated with increases in total and SIV specific Ab levels. 47 There were reports that in the patients infected with worms, T cells in the GC produced lots of IL-4, phenotype of which was alike to Tfh cells, these data indicated that Tfh cell probably takes part in the quick reaction against worm infection. 27,48
Tumor
There were much similarity between angioimmunoblastic T lymphoma (AITL) cells and Tfh cells, that is, they all expressed CD4, Bcl-6, CXCR5, CD40L and PD-1, and could produce the homing molecule --CXCL13. 49 Like Tfh cells, primary cutaneous CD4 + small/medium-sized pleomorphic Tcell lymphoma (CSTCL) cells also expressed Bcl-6, CXCL13 and PD-1. 50 These indicated that Tfh cell is related to development of lymphoma.
Presently, Battistella 51 reported that, due to major Bcell infiltrate and CD10 positive in skin biopsy specimens, some patients were initially misdiagnosed as primary cutaneous follicle B-cell lymphoma, but rituximab-containing therapies were ineffective. In the further study, they found the biopsy specimens after treatment with rituximab showed medium to large-sized atypical T-cell skin infiltrate expressing Tfh cell markers (CD10, Bcl-6, PD-1, CXCL13 and ICOS). Finally, the diagnosis proposed for all patients was cutaneous Tfh lymphoma. According to the diagnosis, the patient with localized disease was successfully treated with radiotherapy.
Prospect
Conclusively, although the characteristic and function were identified, many questions remain unclear. What is the relation between Tfh cell and other T cell subpopulations? What are the detailed mechanisms of Tfh cell and helper B cell? Is there any interaction between Tfh cells and other immune cells? What are the functions of Tfh cells in the progression of lots of infectious diseases, autoimmune diseases and tumor? And is it possible for us to regulate Tfh cell that can influence the treatment of these diseases? There are many other questions also to be addressed. In near future, the researches on Tfh cells probably become a new focus to find out the possible mechanisms of immunodeficiency, infectious diseases, autoimmune diseases and tumor.
